Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Jan 3.

Published in final edited form as: J Clin Virol. 2013 Jun 24;58(1):176–182. doi: 10.1016/j.jcv.2013.05.018

Table 1.

MeV Isolates used in this study.

Genotype	Virus
A	MVi/Edmonston-wt.USA/54^a,^b
B3	MVi/New Jersey.USA/45.05^b,^c
D2	MVi/NewYork.USA/11.00^b
D3	MVi/Illinois.USA/89/1^a,^b
D4	MVi/New York.USA/14.08/1^b
D4	MVi/New York.USA/26.09/3^c
D5	MVi/Pennsylvania.USA/34.07^b
D6	MVi/St. Petersburg.RUS/16.04/4^b
D8	MVi/Vellore.IND/08.05^b
D8	MVi/Virginia.USA/15.09^c
G2	MVi/Amsterdam.NET/49.97^a,^b
G3	MVi/Gresik.INO/18.02^a,^b
H1	MVi/Wisconsin.USA15.08/1^b
H1	MVi/Pennsylvania.USA/20.09^c

^a

Reference strain [6].

^b

Strain used for primer sensitivity tests.

^c

Strain used for FTA^® practice panel.